ArticleCirculation2016

Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT".

Erin A Bohula et al.PubMed ↗Publisher ↗

No numbers read from the abstract.